Central effects of the anabolic steroid 17α methyltestosterone in female anxiety

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 2, 2006, Pages 275-281

  Carlos Rivera Arce, Juan ^a   Morales Crespo, Lizannette ^b   Vargas Pinto, Noelia ^c   Velázquez, Kandy T ^c   Jorge, Juan Carlos ^c  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^b Department of Biology ^*  (Puerto Rico)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Anabolic steroids; Anxiety; Dorsomedial hypothalamus; Elevated plus maze; Social interaction test; Systolic blood pressure; Vogel conflict test

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ANABOLIC AGENT; METHYLTESTOSTERONE; MUSCIMOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; APPETITE; ARTICLE; CONFLICT; DRUG INFUSION; DRUG MECHANISM; FEMALE; FLUID INTAKE; HYPOTHALAMUS NUCLEUS; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUNISHMENT; SOCIAL INTERACTION; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; FEMALE; INTERPERSONAL RELATIONS; METHYLTESTOSTERONE; MUSCIMOL; PYRIDAZINES; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS;

EID: 33746286974     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.05.009     Document Type: Article

References (55)

1. Ågren G., Thiblin I., Tirassa P., Lundeberg T., and Stenfors C. Behavioural anxiolytic effects of low-dose anabolic androgenic steroid treatment in rats. Physiol Behav 66 3 (1999) 503-509
2. Aikey J.L., Nyby J.G., Anmuth D.M., and James P.J. Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm Behav 42 4 (2002) 448-460
3. Bahrke M.S., Yesalis III C.E., and Wright J.E. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update. Sports Med 22 6 (1996) 367-390
4. Barreto-Estrada J., Barreto J., Fortis-Santiago Y., Rivera-Ramos I., Fortis-Santiago A., and Jorge J.C. Modulation of affect after chronic exposure to the anabolic steroid 17α-methyltestosterone in adult mice. Behav Neurosci 118 5 (2004) 1071-1079
5. Beckett S.R., Duxon M.S., Aspley S., and Marsden C.A. Central c-fos expression following 20 kHz/ultrasound induced defence behaviour in the rat. Brain Res Bull 42 6 (1997) 421-426
6. Bellinger L.L., and Bernardis L.L. The dorsomedial hypothalamic nucleus revisited: 1998 update. Soc Exp Biol Med 218 (1998) 284-306
7. Bing O., Heilig M., Kakoulidis P., Sundblad C., Wiklund L., and Eriksson E. High doses of testosterone increase anticonflict behavior in rat. Eur Neuropsychopharmacol 8 (1998) 321-323
8. Bitran D., Kellogg C.K., and Hilvers R.J. Treatment with anabolic-androgenic steroid affects anxiety-related behavior and alters the sensibility of cortical GABA A receptor in the rat. Horm Behav 27 4 (1993) 568-583
9. Cameron O.G., and Hill E.M. Women and anxiety. Psychiatr Clin North Am 1 (1989) 175-186
10. Carboni E., Wieland S., Lan N.C., and Gee K.W. Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety. Psychopharmacology 126 2 (1996) 173-178
11. Conacher G.N., and Workman D.G. Violent crime possibly associated with anabolic steroid use. Am J Psychiatry 146 5 (1989) 679
12. Crawley J.N. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. 1st ed. (2000), Wiley-Liss, New York
13. 3H-muscimol binding in the brain. Pharmacol Biochem Behav 63 4 (1999) 639-646
14. Daly R.C., Su T.P., Schmidt P.J., Pickar D., Murphy D.L., and Rubinow D.R. Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings. Arch Gen Psychiatry 58 2 (2001) 172-177
15. Daly R.C., Su T.P., Schmidt P.J., Pagliaro M., Pickar D., and Rubinow D.R. Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers. Psychoneuroendocrinology 28 3 (2003) 317-331
16. B receptors in the dorsomedial hypothalamus and heart rate in anesthetized rats. Brain Res 788 (1998) 245-250
17. Flores P., and Pellón R. Antipunishment effects of diazepam on two levels of suppression of schedule-induced drinking in rats. Pharmacol Biochem Behav 67 2 (2000) 207-214
18. Franke W.W., and Berendok B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 43 7 (1997) 1262-1279
19. Frye C.A., and Lacey A.H. Posttraining androgens' enhancement of cognitive performance is temporally distinct from androgens' increases in affective behavior. Cogn Affect Behav Neurosci 1 2 (2001) 172-182
20. Genazzani A.R., Stomati M., Bernardi F., Monteleone P., Morittu A., and Luisi M. Dehydroepiandrosterone as neurosteroid: neuroendocrine effects in post-menopausal women. J Endocrinol Invest 22 (1999) 19-23
21. Griebel G., Perrault G., Simiand J., Cohen C., Granger P., Decobert M., et al. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors. J Pharmacol Exp Ther 298 2 (2001) 753-768
22. Haupt H.A., and Rovere G.D. Anabolic steroids: a review of the literature. Am J Sports Med 12 6 (1984) 469-484
23. Inglefield J.R., Schwarzkopf S.B., and Kellogg C.K. Alterations in behavioral responses to stressors fallowing excitoxin lesions of dorsomedial hypothalamic regions. Brain Res 633 (1994) 151-161
24. Jardim M.C., and Guimarães F.S. GABAergic and glutamatergic modulation of exploratory behavior in the dorsomedial hypothalamus. Pharmacol Biochem Behav 69 (2001) 579-584
25. Johnson M.D. Anabolic steroid use in adolescent athletes. Sport Med 37 5 (1990) 1111-1123
26. Johansson P., Lindqvist A., Nyberg F., and Fahlke C. Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. Pharmacol Biochem Behav 67 2 (2000) 271-279
27. Jorge J.C., Velázquez K.T., Ramos D.L., Lorenzini I., Marrero J., and Maldonado-Vlaar C. A testosterone metabolite is rewarding to ovariectomized female rats. Behav Neurosci 119 5 (2005) 1222-1226
28. Keim S.R., and Shekhar A. The effects of GABAA receptor blockade in the dorsomedial hypothalamic nucleus on corticotrophin (ACTH) and corticosterone secretion in male rats. Brain Res 739 (1996) 46-51
29. Lukas S.E. CNS effects and abuse liability of anabolic-androgenic steroids. Ann Rev Pharmacol Toxicol 36 (1996) 333-357
30. Milani H., and Graeff F.G. GABA-benzodiazepine modulation of aversion in the medial hypothalamus of the rat. Pharmacol Biochem Behav 28 (1987) 21-27
31. Millan M.J., and Brocco M. The Vogel Conflict Test: procedural aspects, γ-aminobutyric acid, glutamate, and monoamines. Eur J Pharmacol 463 1-3 (2003) 67-96
32. Narducci W.A., Wagner J.C., Hendrickson T.P., and Jeffrey T. Anabolic steroids-a review of the clinical toxicology and diagnostic screening. Clin Toxicol 28 3 (1990) 287-310
33. Palanza P. Animal models of anxiety and depression: how are females different?. Neurosci Biobehav Rev 3 (2001) 219-233
34. Panksepp J. Affective neuroscience. The foundations of human and animal emotions. 1st ed. (1998), Oxford University Press, New York
35. Parrott A.C., Choi P.Y., and Davies M. Anabolic steroid use by amateur athletes: effects upon psychological mood states. J Sports Med Phys Fitness 34 3 (1994) 292-298
36. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed. (1998), Academic Press, New York
37. Pérez-Acevedo, NL, Lathroum, L, Jorge, JC. The neurosteroid 3αDIOL modulates place preference when infused in the basolateral amygdala according to sex. Behavioral Neuroscience 120(3) (in press).
38. Pigott T.A. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 60 Suppl 18 (1999) 4-15
39. Pope H.G., and Katz D.L. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 145 4 (1988) 487-490
40. Pope H.G., and Katz D.L. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 51 5 (1994) 375-382
41. Rojas Y., Rivera-Ramos I., Rundle V., and Jorge J.C. Modulation of elevated plus maze behavior after chronic exposure to the anabolic steroid 17α-methyltestosterone in adult mice. Horm Behav 49 1 (2006) 123-128
42. Sano K., Mayanagi Y., Sekino H., Ogashiwa M., and Ishijima B. Results of stimulation and destruction of the posterior hypothalamus in man. J Neurosurg 33 6 (1970) 689-707 [Dec]
43. Schulte H.M., Hall M.J., and Boyer M. Domestic violence associated with anabolic steroid abuse. Am J Psychiatry 150 2 (1993) 348
44. Schwerin M.J., Corcoran K.J., Fisher L., Patterson D., Askew W., Olrich T., et al. Social physique anxiety, body esteem, and social anxiety in bodybuilders and self-reported anabolic steroids users. Addict Behav 21 1 (1996) 1-8
45. Seeman T. Developmental influences across the life span. Ann NY Acad Sci 896 (1999) 64-65
46. Shekhar A. GABA receptors in the region of the dorsomedial hypothalamus of rats regulate anxiety in the elevated plus-maze test I. Behavioral measures. Brain Res 627 1 (1993) 9-16
47. Shekhar A., and DiMicco J.A. Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats. Neuropharmacology 26 (1987) 407-417
48. Shekhar A., and Katner J.S. Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test. Pharmacol Biochem Behav 50 2 (1995) 253-258
49. Shekhar A., Hingtgen J.N., and DiMicco J.A. GABA receptors in the posterior hypothalamus regulate experimental anxiety in rats. Brain Res 512 1 (1990) 81-88
50. Shekhar A., Sims L.S., and Bowsher R.R. GABA receptors in the region of the dorsomedial hypothalamus of rats regulate anxiety in the elevated plus-maze test. II. Physiological measures. Brain Res 627 1 (1993) 17-24
51. Shekhar A., Katner J.S., Sajdyk T.J., and Kohl R.R. Role of norepinephrine in the dorsomedial hypothalamic panic response: an in vivo microdialysis study. Pharmacol Biochem Behav 71 3 (2002) 493-500
52. A and excitatory amino acid receptors in dorsomedial hypothalamus and heart rate in rats. Am J Physiol 260 1 (1991) 13-20
53. Su T., Pagliaro M., Schmidt P., Pickar D., Wolkowitz O., and Rubinow D. Neuropsychiatric effects of anabolic steroids in male normal volunteers. J Am Med Assoc 131 1 (1993) 2760-2764
54. Thiblin I., Lindquist O., and Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45 1 (2000) 16-23
55. Vogel J.R., Beer B., and Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21 (1971) 1-7